GSK 1379725A
CAS: 1802251-00-8
Ref. 3D-CXC25100
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
GSK 1379725A is a new drug that has been shown to be effective in the treatment of cancer and inflammatory bowel disease. GSK 1379725A targets the ubiquitin ligases that play a role in protein degradation, leading to the activation of creatine kinase. This enzyme is important for energy production and cellular function. The drug also inhibits inflammation by inhibiting the mineralocorticoid receptor, which is involved in immune system regulation. GSK 1379725A works by generating electrons from oxidation catalysts and transferring them to molecular oxygen through an electron transfer chain reaction. This process leads to the generation of reactive oxygen species (ROS) that can cause oxidative stress and damage DNA, proteins, and lipids.
Propiedades químicas
Consulta técnica sobre: 3D-CXC25100 GSK 1379725A
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
